Bortezomib and dexamethasone for multiple myeloma: higher AST and LDH levels associated with a worse prognosis on overall survival

BACKGROUND: Bortezomib offers a novel approach to the treatment of multiple myeloma producing rapid control. The aim of this study was to investigate the outcomes of bortezomib and dexamethasone-treated patients with multiple myeloma. METHODS: We conducted a retrospective study of 44 consecutively-t...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: Kiba, Takayoshi, Ito, Takuo, Nakashima, Toshihisa, Okikawa, Yoshiko, Kido, Miki, Kimura, Akiko, Kameda, Keita, Miyamae, Fumiaki, Tanaka, Suzuko, Atsumi, Misao, Sumitani, Yoko, Shitakubo, Yoshimi, Niimi, Hiromasa
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: BioMed Central 2014
Θέματα:
Research Article
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4078016/
https://ncbi.nlm.nih.gov/pubmed/24952705
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-14-462
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια